December 1, 2020
The Joint Commission Says Hospitals Should Prioritize Seven Patient Safety Goals in 2021
The Joint Commission’s seven patient safety goals it says should be the prioritized by hospitals in the coming year.
December 1, 2020
The Joint Commission’s seven patient safety goals it says should be the prioritized by hospitals in the coming year.
November 18, 2020
On December 9, MLMIC and HANYS will present “2020 Healthcare Law Review,” a webinar on the recent legislative, regulatory and case law developments that impact the provision of healthcare.
November 16, 2020
The NYS Department of Health directs physicians interested in administering the COVID-19 vaccine in their practice or clinic to enroll in the New York State Immunization Information System.
November 11, 2020
The U.S. Food and Drug Administration has granted Eli Lilly and Company an emergency use authorization for bamlanivimab to treat mild-to-moderate COVID-19 in adult and pediatric patients.
November 6, 2020
To support policyholders as they navigate the pandemic, MLMIC has assembled a summary of predictive tools and technology to guide management and treatment of COVID-19.
November 4, 2020
Improved treatment of COVID-19 is reducing mortality rates among those hospitalized for the infection, but experts caution the virus remains dangerous.
November 4, 2020
A recent settlement issued by the Office for Civil Rights highlights the importance of adhering to HIPAA’s Right of Access Initiative, a directive requiring covered entities to provide patients, upon request, with timely access to their protected health information.
October 30, 2020
Federal agencies warn of a spike in ransomware targeting hospitals and other healthcare organizations, and at least one health system in New York – St. Lawrence Health System – has reported an attack during this recent burst of cybercrimes.
October 28, 2020
The U.S. Food and Drug Administration has approved the antiviral drug remdesivir, sold as Veklury, to treat COVID-19 patients who meet specific criteria.
October 23, 2020
Based on a series of patient testimonials, the National Institute for Health Research says that ‘long COVID’ could actually be up to four different syndromes.